Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8+ regulatory cells

European Journal of Immunology

Volumn 43, Issue 1, 2013, Pages 125-136

  Yao, Yunliang ^a,b   Han, Wenzheng ^c   Liang, Jingjing ^a   Ji, Jian ^d   Wang, Jianli ^a   Cantor, Harvey ^e   Lu, Linrong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HUZHOU UNIVERSITY   (China)

^c ZHEJIANG SCI TECH UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD8+ Treg; Colitis; Inflammation; Qa 1

Indexed keywords

DEXTRAN SULFATE; GLATIRAMER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; ENTERITIS; FEMALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLITIS; CYTOTOXICITY, IMMUNOLOGIC; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOSUPPRESSION; INFLAMMATORY BOWEL DISEASES; MICE; MICE, INBRED C57BL; PEPTIDES; PERFORIN; PROTEIN BINDING; VACCINATION;

EID: 84872491616     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242758     Document Type: Article

References (34)

1. Sartor, R. B., Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006. 3: 390-407.
2. Schreiber, S., Monocytes or T cells in Crohn's disease: does IL-16 allow both to play at that game? Gut 2001. 49: 747-748.
3. Boirivant, M., Marini, M., Di Felice, G., Pronio, A. M., Montesani, C., Tersigni, R. and Strober, W., Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999. 116: 557-565.
4. Strober, W., Fuss, I. J. and Blumberg, R. S., The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 2002. 20: 495-549.
5. Okamoto, S., Watanabe, M., Yamazaki, M., Yajima, T., Hayashi, T., Ishii, H., Mukai, M. et al., A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis. Eur. J. Immunol. 1999. 29: 355-366.
6. Kim, T. I., Lee, Y. C., Lee, K. H., Han, J. H., Chon, C. Y., Moon, Y. M., Kang, J. K. et al., Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect. Immun. 2001. 69: 5056-5063.
7. Wu, C. Y., Wu, M. S., Kuo, K. N., Wang, C. B., Chen, Y. J. and Lin, J. T., Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J. Clin. Oncol. 2010. 28: 2952-2957.
8. + Treg cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
9. Wan, Y. Y. and Flavell, R. A., TGF-beta and regulatory T-cell in immunity and autoimmunity. J. Clin. Immunol. 2008. 28: 647-659.
10. Powrie, F., Leach, M. W., Mauze, S., Caddle, L. B. and Coffman, R. L., Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 1993. 5: 1461-1471.
11. + regulatory T-cells. J. Immunol. 2003. 170: 3939-3943.
12. Poussier, P., Edouard, P., Lee, C., Binnie, M. and Julius, M., Thymus-independent development and negative selection of T cells expressing T-cell receptor alpha/beta in the intestinal epithelium: evidence for distinct circulation patterns of gut- and thymus-derived T lymphocytes. J. Exp. Med. 1992. 176: 187-199.
13. Menager-Marcq, I., Pomie, C., Romagnoli, P., and van Meerwijk, J. P., CD8+CD28- Treg lymphocyte prevent experimental inflammatory bowel disease in mice. Gastroenterology 2006. 131: 1775-1785.
14. Das, G., Augustine, M. M., Das, J., Bottomly, K., Ray, P. and Ray, A., An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc. Natl. Acad. Sic. USA 2003. 100: 5324-5329.
15. Lu, L., Kim, H. J., Werneck, M. B. and Cantor, H., Regulation of CD8+ regulatory T-cells: interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc. Natl. Acad. Sci. USA 2008. 105: 19420-19425.
16. Jiang, H., Kashleva, H., Xu, L. X., Forman, J., Flaherty, L., Pernis, B., Braunstein, N. S. et al., T-cell vaccination induces T-cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T-cells. Proc. Natl. Acad. Sic. USA 1998. 95: 4533-4537.
17. Wu, Y., Zheng, Z., Jiang, Y., Chess, L. and Jiang, H., The specificity of T-cell regulation that enables self-nonself discrimination in the periphery. Proc. Natl. Acad. Sci. USA 2009. 106: 534-539.
18. Aharoni, R., Kayhan, B., Brenner, O., Domev, H., Labunskay, G. and Arnon, R., Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 2006. 318: 68-78.
19. Schrempf, W. and Ziemssen, T., Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun. Rev. 2007. 6: 469-475.
20. Dressel, A., Vogelgesang, A., Brinkmeier, H., Mader, M. and Weber, F., Glatiramer acetate-specific human CD8(+) T-cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment. J. Neuroimmunol. 2006. 181: 133-140.
21. Tennakoon, D. K., Mehta, R. S., Ortega, S. B., Bhoj, V., Racke, M. K. and Karandikar, N. J., Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J. Immunol. 2006. 176: 7119-7129.
22. Hu, D., Ikizawa, K., Lu, L., Sanchirico, M. E., Shinohara, M. L. and Cantor, H., Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 2004. 5: 516-523.
23. Holmen, N., Lundgren, A., Lundin, S., Bergin, A. M., Rudin, A., Sjovall, H. and Ohman, L., Functional CD4+CD25high Treg cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm. Bowel Dis. 2006. 12: 447-456.
24. + Treg cells in the lamina propria of patients with inflammatory bowel disease. J. Immunol. 2005. 174: 5814-5822.
25. Perse, M. and Cerar, A., Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012. 2012: 718617.
26. Axelsson, L. G., Landstrom, E., Goldschmidt, T. J., Gronberg, A. and Bylund-Fellenius, A. C., Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 1996. 45: 181-191.
27. Stevceva, L., Pavli, P., Husband, A. J. and Doe, W. F., The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it. BMC Clin. Pathol. 2001. 1: 3.
28. Dieleman, L. A., Ridwan, B. U., Tennyson, G. S., Beagley, K. W., Bucy, R. P. and Elson, C. O., Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994. 107: 1643-1652.
29. Shintani, N., Nakajima, T., Okamoto, T., Kondo, T., Nakamura, N. and Mayumi, T., Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen. Pharmacol. 1998. 31: 477-481.
30. Kim, T. W., Seo, J. N., Suh, Y. H., Park, H. J., Kim, J. H., Kim, J. Y. and Oh, K. I., Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis. World J. Gastroenterol. 2006. 12: 302-305.
31. Yanaba, K., Asano, Y., Tada, Y., Sugaya, M., Kadono, T. and Sato, S., Proteasome inhibitor bortezomib ameliorates intestinal injury in mice. PLoS One 2012. 7: e34587.
32. Wirtz, S., Neufert, C., Weigmann, B. and Neurath, M. F., Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007. 2: 541-546.
33. Uematsu, S., Fujimoto, K., Jang, M. H., Yang, B. G., Jung, Y. J., Nishiyama, M. and Sato, S. et al., Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 2008. 9: 769-776.
34. Rudolphi, A., Bonhagen, K. and Reimann, J., Polyclonal expansion of adoptively transferred CD4 +alpha beta T cells in the colonic lamina propria of scid mice with colitis. 1996 Eur. J. Immunol. 26: 1156-1163.